| hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$97 |
HPG acquires majority stake in tradie-focused VIZ Insurance
|
30 Apr 2026 8:47AM |
$0.690 |
$0.710 |
risen by
2.90%
|
|
HPG - Price-sensitive ASX Announcement
Full Release
Key Points
- hipages acquires 51% of VIZ Insurance for $1.4 million
- VIZ provides digital insurance for 85+ trade occupations
- Acquisition to enhance customer retention and revenue
- VIZ Tradie Pass offers quick access to insurance certificates
- hipages aims to expand its platform strategy beyond tradie services
- Two Board seats secured by hipages in VIZ
- Options included for future acquisition of remaining VIZ equity
- Acquisition funded from hipages' existing cash reserves
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kincora Copper Limited (KCC) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$16 |
Kincora engages Geomorphic AI
|
30 Apr 2026 8:46AM |
$0.840 |
$0.765 |
fallen by
8.93%
|
|
| Eagle Mountain Mining Limited (EM2) ORDINARY FULLY PAID |
Materials |
$8 |
Oracle Ridge Transaction Completes
|
30 Apr 2026 8:46AM |
$0.010 |
$0.005 |
fallen by
50%
|
|
EM2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Eagle Mountain Mining Limited confirms the completion of the Oracle Ridge transaction with Nittetsu Mining Co.
- Nittetsu has provided US$3.5 million, extinguishing a US$7.25 million loan to Vincere Resource Holdings LLC.
- Nittetsu contributed an additional US$16.5 million for project-related costs, establishing a joint venture where Nittetsu holds 80% and Eagle Mountain retains 20% interest.
- The Oracle Ridge project is located in Arizona, USA, a region known for significant copper discoveries.
- Eagle Mountain's focus remains on developing Oracle Ridge and exploring new opportunities with a debt-free balance sheet.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NeuroScientific Biopharmaceuticals Ltd (NSB) ORDINARY FULLY PAID |
Health Care |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2026 8:46AM |
$0.110 |
$0.060 |
fallen by
45.45%
|
|
NSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful clinical response from early treatments using StemSmart™ for Crohn’s disease.
- Initiated technology transfer for manufacturing with Q-Gen Cell Therapeutics.
- Phase 2 clinical trial preparations progressing with real-world data support.
- Maintained strong cash position of $5.68 million.
- Continued engagement with Key Opinion Leaders and trial sites.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$4,752 |
SEC Schedule 13G
|
30 Apr 2026 8:45AM |
$20.340 |
$26.270 |
risen by
29.15%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,627 |
Appendix 3C
|
30 Apr 2026 8:45AM |
$42.250 |
$41.700 |
fallen by
1.30%
|
|
| Vanguard US Total Market Shares Index ETF (VTS) |
Financials |
$6,869 |
Issuance of a new Australian Prospectus
|
30 Apr 2026 8:45AM |
$491.010 |
$528.380 |
risen by
7.61%
|
|
| Li-S Energy Limited (LIS) ORDINARY FULLY PAID |
Industrials |
$80 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2026 8:43AM |
$0.130 |
$0.125 |
fallen by
3.85%
|
|
LIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflows from operating activities were $419,000 for the quarter.
- Net cash inflows from investing activities totaled $994,000.
- Received first tranche of $1.9 million ARENA funding for Phase 4 Manufacturing Plant feasibility study.
- Expanded Battery Testing Centre to support increased cell production and testing.
- Delivered first battery pack to VTOL Aerospace under the EATP programme.
- Commenced battery design for Praetorian Aeronautics' Dagger Interceptor platform.
- Prepared for extreme-depth UUV testing with MSubs.
- CASA approval received for air transport of Li-S Energy cells.
- Engaged HATCH for Phase 4 manufacturing feasibility study.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stepchange Holdings Limited (STH) ORDINARY FULLY PAID |
Information Technology |
$19 |
Update - Notification of buy-back - STH
|
30 Apr 2026 8:43AM |
$0.150 |
$0.115 |
fallen by
23.33%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,627 |
Appendix 3C
|
30 Apr 2026 8:43AM |
$42.250 |
$41.700 |
fallen by
1.30%
|
|
| Greenwing Resources Ltd (GW1) ORDINARY FULLY PAID |
Materials |
$37 |
Notification regarding unquoted securities - GW1
|
30 Apr 2026 8:43AM |
$0.074 |
$0.072 |
fallen by
2.70%
|
|
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$17 |
Notice of Annual General Meeting/Proxy Form
|
30 Apr 2026 8:42AM |
$0.070 |
$0.065 |
fallen by
7.14%
|
|
| Recharge Metals Limited (REC) ORDINARY FULLY PAID |
Materials |
$27 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2026 8:42AM |
$0.032 |
$0.024 |
fallen by
25%
|
|
REC - Price-sensitive ASX Announcement
Full Release
Key Points
- Recharge Metals Limited held $3,494,569 in cash at the end of March 2026.
- A significant capital raising was completed, involving a placement and a rights issue, raising approximately $5.97 million.
- The funds raised are intended for the Sunset Well Gold Project and general working capital.
- The Sunset Well Project includes the acquisition of tenements and is located near Leonora, Western Australia.
- During the quarter, the company progressed on exploration planning at the Sunset Well.
- Board and management changes were announced to enhance exploration and strategic capabilities.
- The cash flow report (Appendix 5B) includes details of cash movements, financing, and related party payments.
- Exploration activities targeted structural zones such as the Prospero and Flanders Shear Zones.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gold Hydrogen Limited (GHY) ORDINARY FULLY PAID |
Energy |
$70 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2026 8:42AM |
$0.340 |
$0.390 |
risen by
14.71%
|
|
GHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Mobilization of Ramsay flow test program scheduled for late May 2026.
- Significant upgrades in Ramsay wells identified additional porous zones for testing.
- Strong market conditions for helium with potential development in Australia.
- Net cash decrease from operations by $3.06 million for the quarter.
- Financing activities raised $13.792 million during the period.
- Estimated funding available for approximately 4.46 quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Loyal Metals Ltd (LLM) ORDINARY FULLY PAID |
Materials |
$65 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2026 8:42AM |
$0.420 |
$0.430 |
risen by
2.38%
|
|
LLM - Price-sensitive ASX Announcement
Full Release
Key Points
- Loyal Metals Ltd completed a comprehensive geophysical survey using Mobile Magnetotellurics over a 77 km² area.
- The survey revealed significant inferred extensions of lithium pegmatites at the Trieste Lithium Project.
- The Hidden Lake Lithium Project is located 65 km from Yellowknife, NWT, with confirmed mineralised spodumene dykes.
- Notable assay results included significant copper, gold, and silver findings from drillholes.
- The company maintains active and direct interest in numerous mining claims.
- Loyal Metals lodged a prospectus for Desert Minerals, indicating potential expansion or diversification.
- Quarterly activities report includes details on project advancements and exploration targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$32 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2026 8:41AM |
$0.055 |
$0.078 |
risen by
41.82%
|
|
CBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Transition to a distributor-led AAC model in North America.
- Strategic partnership with NextLevel Assistive Technology for iOS device commercialization.
- NeuroNode included in German Statutory Health Insurance Directory.
- Net cash outflows of $1.7 million, cash receipts of $1.2 million.
- Focus on strategic growth in the U.S., Australia, and Japan.
- Impact of NDIS approval delays on Australian operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Inghams Group Limited (ING) ORDINARY FULLY PAID |
Consumer Staple |
$784 |
Change of Registered Office Address
|
30 Apr 2026 8:41AM |
$1.960 |
$2.110 |
risen by
7.65%
|
|
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$29 |
Quotation of Options, Top 20 and Distribution Schedule
|
30 Apr 2026 8:41AM |
$0.150 |
$0.100 |
fallen by
33.33%
|
|
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$41 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2026 8:40AM |
$0.039 |
$0.033 |
fallen by
15.38%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Multi-year collaboration with ITRI and NTU for RRAM platform enhancement.
- Completion of neuromorphic and in-memory processing IP acquisition.
- Cash balance of $3.1 million as of 31 March 2026.
- Net cash used in operating activities was approximately $1.9 million.
- Strategic focus on 'Intelligence at the Ultra Edge' vision.
- Engagement with partners and venture capital firms in Israel for commercialization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Celsius Resources Limited (CLA) ORDINARY FULLY PAID |
Materials |
$17 |
Update on potential assignment of MIC OLSA
|
30 Apr 2026 8:39AM |
$0.008 |
$0.005 |
fallen by
43.75%
|
|
CLA - Price-sensitive ASX Announcement
Full Release
Key Points
- Potential assignment of MIC's loan position under OLSA with MMCI.
- Equinaire Holdings, a subsidiary of Kiri Industries, executed an Assignment Agreement with MIC.
- Transaction to enable preferential copper ore supply for Kiri's facility.
- Celsius advancing funding process for Maalinao-Caigutan-Biyog Copper-Gold Project.
- Indicative non-binding financing proposals received.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$22 |
Quarterly Activities Report /Appendix 4C Cash Flow Statement
|
30 Apr 2026 8:39AM |
$0.014 |
$0.011 |
fallen by
21.43%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- Financial Position: Cash reserves increased to $5.47 million.
- Commercial Momentum: Executed Licence & Supply Agreement with Cadila Pharmaceuticals.
- Post-Quarter Commercial Expansion: Agreement with Zydus Lifesciences Ltd.
- Second Peter Mac Validation Program: Preclinical validation for drug combinations.
- Commercial Team Strengthened: New appointments in leadership roles.
- Board Renewal: Appointment and retirement of key board members.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$92 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2026 8:39AM |
$0.665 |
$0.605 |
fallen by
9.02%
|
|
BB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Onboarding of all Clinical Sites for Pivotal FDA Study completed.
- First Participant Enrolled in FDA 510(k) Pivotal Validation.
- Launch of Nationwide Autism Screening Program in Morocco.
- Expansion of Clinical and Scientific Influence in the U.S.
- Completion of a A$17.5M placement to institutional investors.
- Financial activities included A$1.036 million net cash used in operations.
- Cash balance at 31 March 2026 was A$4.319 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$4,752 |
SEC Schedule 13G
|
30 Apr 2026 8:39AM |
$20.340 |
$26.270 |
risen by
29.15%
|
|
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$3,771 |
Update - Notification of buy-back - AMP
|
30 Apr 2026 8:38AM |
$1.425 |
$1.550 |
risen by
8.77%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$26,433 |
Notification of cessation of securities - BXB
|
30 Apr 2026 8:38AM |
$22.070 |
$19.790 |
fallen by
10.33%
|
|
Call 1300 880 160
Start a chat
Schedule a call
